India's largest listed pharmaceutical company, Sun Pharma spiked by more than 5 per cent in early trade on Monday, on the back of a market buzz that the company's Halol facility will be inspected by the USFDA. At 10:58 hours, the stock of Sun Pharma was quoting 597.30 per share, up 3.21 per cent.